A Single Group Study to Evaluate the Effects of a Multivitamin on a Range of Health and Wellbeing Outcomes.
- Conditions
- Health and Wellbeing
- Interventions
- Dietary Supplement: Multivitamin Supplement
- Registration Number
- NCT06568146
- Lead Sponsor
- Love Wellness
- Brief Summary
This is a hybrid single-group clinical trial that will last 12 weeks. Participants will take 2 capsules daily with the first meal of the day in the morning. Participants will undertake blood tests at Baseline and Week 12. Study-specific questionnaires will be completed at Baseline, Week 4, Week 8, and Week 12. Cognitive Battery Testing will take place at Baseline, Week 4, Week 8, and Week 12.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 40
- Female at birth.
- Aged 18+.
- Interested in supporting their health and wellbeing.
- Not planning to introduce or change prescription medications, vitamins, minerals, or supplements one month prior to and during the study.
- Generally healthy with no uncontrolled chronic conditions.
- Recent surgeries or invasive treatments.
- Introduction of new health-related products in the last 12 weeks.
- Allergies to product ingredients or use of Epi-Pen.
- Chronic health conditions affecting participation.
- Endocrine or glucose-related disorders, including diabetes.
- Hematological disorders, including anemia.
- Pregnant, breastfeeding, or planning to conceive.
- History of substance abuse or recent smoking.
- Unwillingness to follow the study protocol.
- Participation in other clinical trials.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Multivitamin Supplement Group Multivitamin Supplement Participants in this arm will take 2 capsules of the multivitamin supplement daily with the first meal of the day in the morning.
- Primary Outcome Measures
Name Time Method Changes in Blood Levels of Vitamin B12 Baseline and Week 12 This outcome measure will assess the effect of the multivitamin supplement on serum levels of Vitamin B12.
Changes in Blood Levels of Insulin Baseline and Week 12 This outcome measure will assess the effect of the multivitamin supplement on serum levels of Insulin.
Changes in Blood Levels of Vitamin D Baseline and Week 12 This outcome measure will assess the effect of the multivitamin supplement on serum levels of Vitamin D.
Changes in Blood Levels of Iron Baseline and Week 12 This outcome measure will assess the effect of the multivitamin supplement on serum levels of Iron.
- Secondary Outcome Measures
Name Time Method Participants' Perceptions of Health and Wellbeing Baseline, Week 4, Week 8, and Week 12 Evaluation of participants' perceptions via a questionnaire exploring the convenience and efficacy of the multivitamin supplement in supporting overall health and wellbeing.
Trial Locations
- Locations (1)
Citruslabs
🇺🇸Santa Monica, California, United States